Z. Dziewanowski

Phase II study of recombinant leukocyte a interferon (rIFN‐αA) in disseminated malignant melanoma

D. Ahmann, S. Green, E. Creagan, 1984, Cancer.

Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

T. Merigan, S. Horning, J. Quesada, 1982, Annals of internal medicine.

Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanoma.

D. Ahmann, S. Green, E. Creagan, 1984, Cancer.